Calamos Advisors’s Immunomedics Inc IMMU Stock Holding History

Calamos Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-94,422	Closed	-$8.03M	–	781
2020 Q3	$8.03M	Buy	94,422 +40,038	+74%	+$2.02M	0.05%	350
2020 Q2	$1.93M	Buy	+54,384	New	+$1.59M	0.01%	583

Calamos Advisors's IMMU Position: Q4 2020 in Review

Calamos Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 94,422 shares — an estimated $8.03M sold.

Calamos Advisors first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $8.03M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Calamos Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Calamos Advisors sold 94,422 Immunomedics Inc shares in Q4 2020, an estimated $8.03M.
Calamos Advisors first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
Calamos Advisors's Immunomedics Inc position peaked at $8.03M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Calamos Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.